BMRN FY 2017 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.3B+17.6% YoY

Gross Profit

$1.1B81.6% margin

Operating Income

-$15M-1.1% margin

Net Income

-$117M-8.9% margin

EPS (Diluted)

$-0.67

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$208M

Stock-Based Comp.

$140M

Balance Sheet

Total Assets

$4.6B

Total Liabilities

$1.8B

Stockholders' Equity

$2.8B

Cash & Equivalents

$598M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.1B	+17.6%
Gross Profit	$1.1B	$907M	+18.1%
Operating Income	-$15M	-$803M	+98.2%
Net Income	-$117M	-$630M	+81.4%